EDCTP-AIGHD Special Session at the Virtual Global Forum on TB Vaccines: Launch of a Global Roadmap

20 Apr 2021 18:00 - 20 Apr 2021 19:30
Type of event EDCTP meeting
Scope TB Roadmap Launch

EDCTP-AIGHD Special Session at the Virtual Global Forum on TB Vaccines – Accelerating TB vaccine research and development: Launch of a Global Roadmap


Responsible for more than 1.4 million deaths a year, TB is a major global public health challenge. Ambitious global TB control goals have been established, but it is widely recognised that these will not be achieved without safe and effective vaccines. Addressing this gap will require coordinated cross-sectoral partnerships and a focus on “end-to-end” clinical development, from early-stage discovery research through to programmatic implementation.

The Global TB Vaccine R&D Roadmap was commissioned by the European & Developing Countries Clinical Trials Partnership (EDCTP) to the Amsterdam Institute for Global Health and Development (AIGHD) to identify priorities to coordinate global action to accelerate the development and implementation of new TB vaccines. The Roadmap has been developed through an iterative global consultative process designed to identify the key barriers to TB vaccine R&D and implementation, and potential ways in which they might be overcome. It is intended to provide a shared set of priorities to guide the activities of all stakeholders with an interest in TB vaccine development and use.

AIGHD and EDCTP are pleased to invite the global TB vaccine community and interested stakeholders to attend the official launch of the Roadmap. The session opens with an introduction to the Roadmap, followed by an overview of current challenges and opportunities for TB vaccine R&D, and the perspective from a community representative. The presentations will be followed by a panel discussion with a diverse group of stakeholders, each sharing their comments on the Roadmap, their views on how they are planning to use it, and how they consider it can guide the future development of TB vaccines.

When: 20 April 2021, 18:00-19:30 CEST

Where: Virtual (Zoom)

REGISTER NOW: https://zoom.us/webinar/register/WN_pbpKgGpRR6ejZN1B-i0bxQ


Speakers and participation

The session will be chaired by Professor Mark Hatherill, South African Tuberculosis Vaccine Initiative (SATVI), South Africa and  Dr Matteo Zignol, Global TB Programme, World Health Organisation (WHO).

Speakers and pannelists:

  • Frank Cobelens, Amsterdam Institute for Global Health and Development (AIGHD), Netherlands
  • Willem Hanekom, Africa Health Research Institute (AHRI), South Africa
  • Blessina Kumar, Global Coalition of TB Activists (GCTA)
  • Videlis Nduba, Kenya Medical Research Institute (KEMRI), Kenya
  • Ann Ginsberg, Bill and Melinda Gates Foundation
  • Birgitte Giersing, Immunization, Vaccines and Biologicals (IVB), World Health Organisation
  • Rajinder Suri, Developing Countries Vaccine Manufacturers Network (DCVMN)
  • Agnès Saint-Raymond, European Medicines Agency (EMA)
  • Michael Makanga, European & Developing Countries Clinical Trials Partnership (EDCTP)

This is an open event, and we encourage researchers and all other interested stakeholders interested in this topic to participate.


The programme includes presentations and panel discussions on the following topics:


  • The TB Vaccine R&D Roadmap: actions and enabling considerations
  • Opportunities for TB Vaccine R&D
  • A community perspective on the TB Vaccine R&D Roadmap